Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001193125-25-283564

Chief Commercial Officer sold 8,887 shares at $11.18 ($99,329)

  • Chief Commercial Officer acquired 48,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Powl Brian T. · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-13 Grant or award : show line 1 in the form +48,900 148,576 D
2025-11-14 Sale : show line 2 in the form −8,887 $11.18 $99,329 139,689 D
Open-market sales · 8,887 sh · avg $11.18 · $99,329
Loading xslF345X05/ownership.xml…